Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Moosig

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|January 27, 2011
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic studyJochen Zwerina, Christian Bach, Davide Martorana, et al.
Clinical and Experimental Rheumatology|April 24, 2010
Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polypsMartin Laudien, Stefan D Gadola, Rainer Podschun, et al.
Journal of Autoimmunity|January 2, 2017
Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitisAnja Kerstein, Silke Schüler, Otávio Cabral-Marques, et al.
Rheumatology (Oxford, England)|August 23, 2015
Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohortJan H Schirmer, Marvin N Wright, Reinhard Vonthein, et al.
Zeitschrift Fur Rheumatologie|December 6, 2017
[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis]Jan Henrik Schirmer, Peer M Aries, Kirsten de Groot, et al.
Rheumatology (Oxford, England)|April 22, 2026
Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert surveyEdoardo Conticini, Giacomo Emmi, Silvia Grazzini, et al.
Zeitschrift Fur Rheumatologie|August 7, 2020
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]Hendrik Schulze-Koops, Christof Iking-Konert, Jan Leipe, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
Zeitschrift Fur Rheumatologie|July 26, 2021
[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]Christof Specker, Peer Aries, Jürgen Braun, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|January 27, 2011
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic studyJochen Zwerina, Christian Bach, Davide Martorana, et al.
Clinical and Experimental Rheumatology|April 24, 2010
Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polypsMartin Laudien, Stefan D Gadola, Rainer Podschun, et al.
Journal of Autoimmunity|January 2, 2017
Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitisAnja Kerstein, Silke Schüler, Otávio Cabral-Marques, et al.
Rheumatology (Oxford, England)|August 23, 2015
Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohortJan H Schirmer, Marvin N Wright, Reinhard Vonthein, et al.
Zeitschrift Fur Rheumatologie|December 6, 2017
[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis]Jan Henrik Schirmer, Peer M Aries, Kirsten de Groot, et al.
Rheumatology (Oxford, England)|April 22, 2026
Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert surveyEdoardo Conticini, Giacomo Emmi, Silvia Grazzini, et al.
Zeitschrift Fur Rheumatologie|August 7, 2020
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]Hendrik Schulze-Koops, Christof Iking-Konert, Jan Leipe, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
The New England Journal of Medicine|May 18, 2017
Mepolizumab or Placebo for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Praveen Akuthota, David Jayne, et al.
Zeitschrift Fur Rheumatologie|July 26, 2021
[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]Christof Specker, Peer Aries, Jürgen Braun, et al.
Pageof 8